Clinical trial
Phase 2-3 - Memantine for Disability in Amyotrophic Lateral Sclerosis
NCT00353665 is registered in ClinicalTrials.gov with University of Lisbon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2-3 - Memantine for Disability in Amyotrophic Lateral Sclerosis
- Lead sponsor
- University of Lisbon
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- January 31, 2009
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.